RAMSAY SANTE : date of approval of the final consolidated financial statements for the year ending June 2021

NEXT STORY
Revive Therapeutics Included in AdvisorShares® Newly Launched Psychedelics ETF
PREV STORY
AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board
Subscribe to PM360
Follow Us

Experts on Call

Get in touch with PM360 Experts On Call

Ads

You May Also Like

Mateon Announces New Preclinical Data Demonstrating Enhanced Tumor Immune Responses when CA4P is Given in Combination with Checkpoint Inhibitors

· CA4P and checkpoint inhibitor combination nearly doubles amount of tumor necrosis SOUTH SAN FRANCISCO, ...

author_avatar
NASDAQ Market News

Albireo Provides First Quarter 2018 Business Update

 First patient enrolled in Phase 3 trial of IBAT inhibitor A4250 in PFIC   Elobixibat ...

author_avatar
NASDAQ Market News

Cue Biopharma to Host Investor Business Update Call and Webcast

Update on progress of selective immune modulation platformCAMBRIDGE, Mass., May 10, 2018 (GLOBE NEWSWIRE) ...

author_avatar
NASDAQ Market News